← All updates

ABRY Partners LLC

ABRY-backed Centauri acquires Benny the Benefits Navigator

September 15, 2026 press release Manager profile

Summary: Centauri Health Solutions announced that it acquired Benny the Benefits Navigator, with the announcement saying the transaction was supported by Centauri's lead investor, ABRY Partners. The item is framed as an ABRY-backed portfolio-company add-on, not as a direct ABRY acquisition or a fund-level transaction.

Why it matters: The update may matter to due-diligence readers as a public signal about add-on activity at an ABRY-backed healthcare-administration platform, while the announcement should not be used to infer product effectiveness, operating outcomes, transaction economics, returns, or investment merit.

9AT filing context: Use only narrow public ADV/profile identity background: ABRY Partners LLC maps to CRD 161154, SEC file 801-74147, and about $15.0B in ADV-reported profile scale. No 13F or Form 5500 context is included because those filings do not explain this portfolio-company add-on acquisition.

Summary

Centauri Health Solutions announced that it acquired Benny the Benefits Navigator, a benefits-navigation and enrollment support business. The accessible Business Wire mirror says the acquisition was supported by Centauri’s lead investor, ABRY Partners.

This draft treats the item as an ABRY-backed portfolio-company add-on acquisition, not as ABRY directly acquiring Benny or as a fund-level transaction. Product, AI, eligibility, application-experience, client, member-impact, and growth claims are attributed to the announcement rather than adopted as 9AT conclusions.

Why it matters

For due-diligence readers, the useful signal is that an ABRY-backed healthcare-administration platform is adding capability through a source-announced acquisition. Add-on activity at a sponsored platform can help readers track sponsor/platform strategy, acquisition cadence, operating focus, and where a manager-backed company is trying to extend its workflow footprint.

The signal is limited. The source supports the announced Centauri/Benny transaction and ABRY’s lead-investor support role, but it does not independently validate product effectiveness, integration results, healthcare operating outcomes, customer adoption, transaction economics, valuation, fund returns, or investment merit.

Source notes

9AT filing context

Public ADV/profile identity context maps ABRY Partners LLC to CRD 161154, SEC file 801-74147, and about $15.0 billion in ADV-reported profile scale. That context is useful only to identify the adviser/platform behind the ABRY sponsor reference.

No 13F or Form 5500 context is included for this item. Public-equity holdings and employee-benefit-plan filings do not explain Centauri’s add-on acquisition, Benny’s product claims, integration outcomes, healthcare-administration quality, transaction economics, or investment merit.

What to watch

Watch for Centauri, ABRY, Benny, Business Wire, or regulator/source-party updates that confirm closing mechanics, integration details, ownership structure, product rollout, or further add-on activity around Centauri.

Also watch future ABRY healthcare-platform updates to distinguish a one-off add-on from a broader pattern of platform expansion, continuation-vehicle activity, or portfolio-company repositioning.

Source links